Table 4 Types of contraceptive method used among HIV- positive and HIV-negative individuals
From: Contraceptive use among HIV-positive and negative women: implication to end unintended pregnancy
Method preference | HIV- Positive (294,93.63) | HIV-Negative (424, 73.1) | X2 -test, p-value |
|---|---|---|---|
Oral contraceptive pills (OCP) of available type | 22(7%) | 48(12.1%) | 2.6,p < 0.05 |
Injectable (Depot) | 81(25.8%) | 294(50.1%) | 1.03, p < 0.05 |
Implant (Jadelle or Implanon) | 16(5.1%) | 40(6.9%) | 4.01, p < 0.05 |
Intra uterine contraceptive device (IUCD) | 89(28.4%) | 17(2.9%) | 1.9, p < 0.05 |
Consistent male condom use | 84(26.7%) | 23(3.9%) | 2.8. p < 0.05 |
Consistent female condom use | 2(0.6%) | 2(0.3%) | 2.7, p < 0.05 |
Dual contraceptive methods (condom and hormonal methods) | 20(6.4%) | 0(0%) | 1.56, p < 0.05 |